Log on / register
Feedback | Support | My details
Endothelin receptors as novel targets in tumor therapy.
Bagnato A, Natali PG
J Transl Med 2004 May 27, 2:16
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.
37%37%


 Research article    
Frequent loss of endothelin-3 (EDN3) expression due to epigenetic inactivation in human breast cancer
Wiesmann F, Veeck J, Galm O, Hartmann A, Esteller M, Knüchel R, Dahl E
Breast Cancer Research 2009, 11:R34 (15 June 2009)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles]
2.
37%37%


 Review    
Targeting targeted agents: open issues for clinical trial design
Bria E, Di Maio M, Carlini P, Cuppone F, Giannarelli D, Cognetti F, Milella M
Journal of Experimental & Clinical Cancer Research 2009, 28:66 (22 May 2009)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles]
3.
37%37%


 Research article    
An expression signature of syndecan-1 (CD138), E-cadherin and c-met is associated with factors of angiogenesis and lymphangiogenesis in ductal breast carcinoma in situ
Götte M, Kersting C, Radke I, Kiesel L, Wülfing P
Breast Cancer Research 2007, 9:R8 (23 January 2007)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]

This article is also cited by a further 1 article in PubMed Central

printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.